BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-9 out of 9 found
  Current Search:  bleomycin: 9     

HTML
100%
Investigators Debate Use of BEACOPP Versus ABVD fo
In recent years, clinicians have debated the merits of two combination drug regimens for patients with advanced-stage Hodgkin's lymphoma-ABVD (doxorubicin, bleomycin, vincristine and dacarbazine) and BEACOPP (bleomycin, etoposide...
Pharmacy Practice News:  Jan 2 2009 5:33AM
Matching: bleomycin
Find similar documents
HTML
100%
Investigators Debate Use of BEACOPP Versus AB
In recent years, clinicians have debated the merits of two combination drug regimens for patients with advanced-stage Hodgkin's lymphoma-ABVD (doxorubicin, bleomycin, vincristine and dacarbazine) and BEACOPP (bleomycin, etoposide...
Pharmacy Practice News:  Dec 18 2008 8:31PM
Matching: bleomycin
Find similar documents
HTML
100%
[Lymphoma and Myeloma] Natural History of CNS Relapse in Patients With Aggressive Non-Hodgkin's Lymphoma: A 20
This Article Google Scholar Accepted July 28, 2008 Natural History of CNS Relapse in Patients With Aggressive Non-Hodgkin's Lymphoma: A 20-Year Follow-Up Analysis of SWOG 8516The Southwest Oncology Group Steven H.

Bernstein,* Joseph M.

Journal of Clinical Oncology:  Dec 7 2008 12:35PM
Matching: bleomycin
Find similar documents
HTML
100%
CytRx Unveils Clinical Development Plan for Pipeline Assets
Editors/Health/Medical Writers LOS ANGELES--(BUSINESS WIRE)--December 3, 2008--CytRx Corporation (NASDAQ: CYTR) today unveiled its corporate strategy to focus its internal resources on the clinical development of oncology drug candidates...
Pharmacy Choice:  Dec 4 2008 12:50AM
Matching: bleomycin
Find similar documents
HTML
100%
CytRx Unveils Clinical Development Plan for Pipeline Assets
- CytRx Corporation (NASDAQ: CYTR) today unveiled its corporate strategy to focus its internal resources on the clinical development of oncology drug candidates tamibarotene and INNO-206, which the Company believes offer the greatest mix of...
DiGiTAL50:  Dec 3 2008 8:42PM
Matching: bleomycin
Find similar documents
HTML
100%
CytRx Unveils Clinical Development Plan For Pipeline Assets
CytRx Corporation (NASDAQ: CYTR) today unveiled its corporate strategy to focus its internal resources on the clinical development of oncology drug candidates tamibarotene and INNO-206, which the Company believes offer the greatest mix of...
Pharmaceutical Online:  Dec 3 2008 7:05PM
Matching: bleomycin
Find similar documents
HTML
100%
CytRx Unveils Clinical Development Plan for Pipeline Assets
CytRx Corporation (NASDAQ: CYTR) today unveiled its corporate strategy to focus its internal resources on the clinical development of oncology drug candidates tamibarotene and INNO-206, which the Company believes offer the greatest mix of...
Genetic Engineering News:  Dec 3 2008 2:28PM
Matching: bleomycin
Find similar documents
HTML
100%
CytRx Unveils Clinical Development Plan for Pipeline Assets
Names World-Renowned Cancer Drug Expert Dr.

Joseph Rubinfeld as Chief Scientific Advisor LOS ANGELES--(BUSINESS WIRE)--Dec 3, 2008 - CytRx Corporation (NASDAQ: CYTR) today unveiled its corporate strategy to focus its internal resources on...

Pharma Live:  Dec 3 2008 2:07PM
Matching: bleomycin
Find similar documents
HTML
100%
Method for treating cancer patients undergoing chemotherapy
Title: United States Patent: 7,439,234 Inventors: Hirschman; Shalom Z.

(Riverdale, NY) Assignee: Advanced Viral Research Corporation (Yonkers, NY) Appl.

No.: 10/456,668 Filed: June 5, 2003 Web Seminars-- Pharm/Biotech/etc.

A method for...

PharmCast:  Nov 6 2008 4:46AM
Matching: bleomycin
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.